Quantcast

Latest ARYx Therapeutics Stories

2008-11-04 09:00:30

ARYx Therapeutics, a biopharmaceutical company, has completed enrollment in EmbraceAC, a Phase II/III double-blind clinical trial comparing its oral anticoagulation therapy, ATI-5923, against the leading anticoagulant agent, warfarin.

2008-08-29 12:01:17

ARYx Therapeutics, a biopharmaceutical company focused on developing a portfolio of potentially safer oral drugs, has appointed David Beier to its board of directors.


Word of the Day
metagrabolized
  • totally perplexed and mixed up.
The word 'metagrabolized' is also spelled 'metagrobolized'.
Related